Explore the serious risks of long COVID and its potential impact on health. Can lingering symptoms from COVID-19 be fatal?
A treatment for fatal lung diseases such as idiopathic pulmonary fibrosis is being developed by Lung Therapeutics. The novel mechanism could have wider applications for other fibrotic diseases.
"I was diagnosed with pulmonary fibrosis, which is the scarring of the lungs, which, when your lungs are scarred, it's harder for the oxygen to go to your blood, so your blood/oxygen levels drop ...
Pulmonary fibrosis is a relentless, potentially fatal disease where lung tissue scars and hardens over time. Often tied to smoking, the illness impairs lung function so that patients become short of ...
The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...
A woman wed her husband in hospital just 48 hours before he died — after the couple's life was 'turned upside down' by his ...
Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
The primary goal of the research will be to understand how dysfunctional lung epithelial cells contribute to causing and perpetuating pulmonary fibrosis, according to the release. These cells ...
The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...
Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...
Hepatic veno-occlusive disease has been reported. Miscellaneous: Other reported adverse reactions include pulmonary fibrosis (including fatal outcomes) and interstitial pneumonitis, skin ...